The first and only fully-automated, random access, multiplex solution for Celiac IgA and Celiac IgG autoantibody testing.

Similar documents
The first and only fully-automated, random access, multiplex solution for Celiac IgA and Celiac IgG autoantibody testing.

Epidemiology. The old Celiac Disease Epidemiology:

DEAMIDATED GLIADIN PEPTIDES IN COELIAC DISEASE DIAGNOSTICS

Diagnostic Testing Algorithms for Celiac Disease

Enhancing the Flexibility of the NGC Chromatography System: Addition of a Refractive Index Detector for Wine Sample Analysis

See Policy CPT CODE section below for any prior authorization requirements

BIOPSY AVOIDANCE IN CHILDREN: THE EVIDENCE

November Laboratory Testing for Celiac Disease. Inflammation in Celiac Disease

Coeliac disease. Do I have coeliac. disease? Diagnosis, monitoring & susceptibilty. Laboratory flowsheet included

Celiac & Gluten Sensitivity; serum

Primary Care Update January 26 & 27, 2017 Celiac Disease: Concepts & Conundrums

Is It Celiac Disease or Gluten Sensitivity?

ab Anti-Deamidated Gliadin Peptide (DGP) IgG ELISA Kit

AMERICAN PECAN COUNCIL. Pecan Industry Position Report. For the Crop Year Ended August 31, 2018

Gluten-Free China Gastro Q&A

OHTAC Recommendation

The IWSR Global LOCAL KNOWLEDGE, GLOBAL INTELLIGENCE

AMERICAN PECAN COUNCIL. Shipments and Inventory on Hand. For the One Month Ended November 30, 2018

AMERICAN PECAN COUNCIL. Shipments and Inventory on Hand. For the One Month and Five Months Ended January 31, 2019

Gluten Sensitivity Fact from Myth. Disclosures OBJECTIVES 18/09/2013. Justine Turner MD PhD University of Alberta. None Relevant

TEST BULLETIN SUMMARY

DESSERT INSPIRATION FACTS AND FIGURES GLOBAL PRODUCT TRENDS VIOGERM WHEAT GERMS OUR PROPOSALS

Disclosures GLUTEN RELATED DISORDERS CELIAC DISEASE UPDATE OR GLUTEN RELATED DISORDERS 6/9/2015

WINE EXPORTS. February Nadine Uren. tel:

Effect of new markets on the supply-demand balance

@WineIntell Wine Intelligence

Diagnosis Diagnostic principles Confirm diagnosis before treating

Improving allergy outcomes. IgE and IgG 4 food serology in a Gastroenterology Practice. Jay Weiss, Ph.D and Gary Kitos, Ph.D., H.C.L.D.

Wine Intelligence Compass

March Monthly Update, Quest Diagnostics Nichols Institute, Valencia

Industry Advisory Panel Item 4c Trade of Stainless Steel Scrap

Compiled by PPL Research Ltd with the assistance of PAA members. uary to December 2012

2018 World Vitiviniculture Situation. OIV Statistical Report on World Vitiviniculture

Evidence Based Guideline

Major California Agricultural Exports to the Top Destinations in 1999* (1) Canada Rank Approximate Export Value (millions)

PHILIPPINES. 1. Market Trends: Import Items Change in % Major Sources in %

Use of Accelerated Solvent Extraction (ASE) with Centrifugal Evaporation to Automate Fat Determination in Chocolate

Gluten sensitivity in Multiple Sclerosis Experimental myth or clinical truth?

Bearing Produced by IAR Team Focus Technology Co., Ltd.

Richard Girardot chief Executive Officer. Vevey, December 2 nd, 2009

University of Tampere, Faculty of Medicine and Life Sciences Arvo building, Arvo Ylpön katu 34, Tampere, Finland

CONTEMPORARY CONCEPT ON BASIC APSECTS OF GLUTEN-SENSITIVE ENTEROPATHY IN ELDERLY PATIENTS

QUANTA Lite TM Gliadin IgG II For In Vitro Diagnostic Use CLIA Complexity: High

SPECIMEN REQUIREMENTS. Specimen Specimen Volume (min) Specimen Type Specimen Container Transport Environment

YUM! Brands Inc. Restaurant Units Activity Summary December 31, 2011 Total

Are we loosing the young generation? Amund Bråthen Senior Advisor Estoril February 7 th 2019

QUANTA Lite TM h-ttg Screen For In Vitro Diagnostic Use CLIA Complexity: High

World Yoghurt Market Report

COMPANY PROFILE Verdeoro srl.

Celiac disease (CD) is a gluten-sensitive enteropathy with. Comparative Usefulness of Deamidated Gliadin Antibodies in the Diagnosis of Celiac Disease

GliaDea IgA ELISA. Gliadin IgA ELISA Assay Kit 1/7 Catalog Number: GDA31-K01. INTENDED USE

Introduction. Copyright - The IWSR 2009 Page 1

YUM! Brands Inc. Restaurant Units Activity Summary June 16, 2012 Total

Challenges in Celiac Disease. Adam Stein, MD Director of Nutrition Support Northwestern University Feinberg School of Medicine

Meredythe A. McNally, M.D. Gastroenterology Associates of Cleveland Beachwood, OH

2013Q2 Daily Chemical Produced by IAR Team Focus Technology Co., Ltd.

Diseases of the gastrointestinal system Dr H Awad Lecture 5: diseases of the small intestine

Fluid Automation Solutions. for Winemaking.

The Future of the Ice Cream Market in Finland to 2018

Natural sourdough for best fermentation flavour

Magnetic Luminex Assay

ASCA IgG ELISA. ASCA IgG ELISA Assay Kit 1/7 Catalog Number: ASG31-K01. INTENDED USE

P E C A N R E P O R T

RIDASCREEN Gliadin. Validation Report. R-Biopharm AG. Art.No. R7001

Name of Policy: Serologic Diagnosis of Celiac Disease

Ceramic Sanitary Ware Produced by IAR Team Focus Technology Co., Ltd.

International Journal of Health Sciences and Research ISSN:

World Cocoa and CBE markets. Presentation to Global Shea 2014 By Owen Wagner, LMC International, Raleigh, NC

Luminex Assay. Mouse Premixed Multi-Analyte Kit. Catalog Number LXSAMS

World vitiviniculture situation

ASCA IgA ELISA. Catalog Number: ASA31-K01. Saccharomyces cerevisiae in human serum. ASCA IgA ELISA Assay Kit 1/7 Catalog Number: ASA31-K01

Original Policy Date

About Us. Based in Portishead, Bristol, United Kingdom T&G s core business is to design and produce for the home, export, retail

Celiac Disease. Sheryl Pfeil, MD The Ohio State University Division of Gastroenterology, Hepatology, and Nutrition. January 2015

Global Trade in Mangoes

LETTER FROM THE EXECUTIVE DIRECTOR

Update on Celiac Disease: New Standards and New Tests

Sheila E. Crowe, MD, FACG

Protect Your Mass Spec

An insight into the viticulture sector

Magnetic Luminex Assay

Gliadin IgG ELISA Assay Kit

Peter HR Green MD. Columbia University New York, NY

Follow-up Management of Patients with Celiac Disease: Resource for Health Professionals

Where boutique wine producers and wine importers connect

World Beer Cup Overview

Celiac Disease 1/13/2016. Objectives. Question 1. Understand the plethora of conditions or symptoms that require testing for Celiac Disease (CD)

Baboons Affected by Hereditary Chronic Diarrhea as a Possible Non-Human Primate Model of Celiac Disease

Celiac Disease and Immunoglobulin A Deficiency: How Effective Are the Serological Methods of Diagnosis?

Coffee Consumption and Mortality for Prostate Cancer. From the Department of Hygiene, Tohoku University School of Medicine, Sendai

Joint Working Group Webinar Series

Comparison of Commercially Available Serologic Kits for the Detection of Celiac Disease

Screening for Celiac Disease: A Systematic Review for the U.S. Preventive Services Task Force

Medical Policy An independent licensee of the Blue Cross Blue Shield Association

Screening for Celiac Disease: A Systematic Review for the U.S. Preventive Services Task Force

Research Article Analytical and Clinical Comparison of Two Fully Automated Immunoassay Systems for the Diagnosis of Celiac Disease

Celiac Disease and Non Celiac Gluten Sensitivity. John R Cangemi, MD Mayo Clinic Florida

Celiac Disease For Dummies By Sheila Crowe, Ian Blumer READ ONLINE

W or ld Cocoa and CBE mar kets. Presentation to Global Shea 2013 By Richard Truscott, LMC International, Oxford, UK

PROWEIN BUSINESS REPORT Prof. Dr. Simone Loose, Evelyn Pabst M. Sc. Geisenheim University, Institute of Wine and Beverage Business Research

Transcription:

Bio-Rad Laboratories bioplex 2200 SYSTEM BioPlex 2200 Celiac IgA and IgG Kits * The first and only fully-automated, random access, multiplex solution for Celiac IgA and Celiac IgG autoantibody testing. The BioPlex 2200 System is designed to handle increasing testing volumes while streamlining workflow. *Not available in the U.S.

Bio-Rad Laboratories bioplex 2200 system Like no other The Celiac IgA and IgG kits are multiplex flow immunoassays for the semi-quantitative detection of IgA and IgG autoantibodies to tissue Transglutaminase (ttg) and deamidated gliadin peptide (DGP). These tests are used as an aid in the diagnosis of Celiac Disease (glutensensitive enteropathy). Celiac Disease is an autoimmune disorder characterized by glutensensitivity. The prevalence of the disease is increasing worldwide in both children and adults. This condition may present with classic symptoms such as failure to thrive, short stature and gastrointestional disorders or more non-specific symptoms such as anemia and chronic fatigue. Some patients with Celiac Disease may even be asymptomatic. BioPlex 2200 Celiac IgA kit contains: Anti-tTG IgA Anti-DGP IgA IgA Verification Bead BioPlex 2200 Celiac IgG kit contains: Anti-tTG IgG Anti-DGP IgG

Early diagnosis and adherence to a gluten-free diet are critical in relieving symptoms and reducing the risk of complications including secondary autoimmune disorders and lymphoma. An accurate and timely diagnosis is imperative to improving patient outcomes. The BioPlex 2200 Celiac IgA and IgG kits incorporate unique bead technology, like no other, for efficient laboratory workflow, excellent clinical performance, high throughput and timely reporting of results. Unique IgA Verification Bead Ensures Confidence in Patient Results The Celiac IgA kit includes a novel IgA Verification Bead (AVB) to accurately identify IgA deficiency. This condition is more prevalent in Celiac Disease patients than in the general population. It is important to recognize this condition in the diagnostic workup because many antibody tests used to diagnose Celiac Disease detect autoantibodies of the IgA isotype. The flag is based on the actual measurement of Total IgA. This is in contrast to the estimation of the IgA level using the anti-ttg IgA signal as is sometimes done with traditional Celiac immunoassays. AVB identifies the 2-5% of Celiac patients with IgA deficiency, so Celiac IgG autoantibodies may be assayed The AVB identifies patient samples with IgA deficiency. This reduces false negative results compared to traditional immunoassays for a comprehensive diagnostic workup Improved Lab Workflow Faster turnaround time Time to first result is approximately 45 minutes 100 samples per hour or 200 test results per hour for anti-ttg & anti-dgp IgA or IgG Eliminate batching and reduce turnaround time The BioPlex 2200 System demonstrates the highest throughput in the market for Celiac testing Simplify workflow With the AVB, it may no longer be necessary to order a Total IgA test before running Celiac Disease serological tests for IgA autoantibodies Two small 5µL samples for four analytes significantly reduces sample volume requirements and tube handling Unlike traditional EIA kits, the Celiac IgA and Celiac IgG kits employ a 30 day calibration curve eliminating the cost of daily calibration

Market Leading Performance Clinically relevant results Measures anti-ttg autoantibodies to greater than ten times the cutoff as recommended by current clinical guidelines Detects autoantibodies to deamidated gliadin peptide offering increased sensitivity and specificity over native gliadin assays Provides an optimal method for evaluating levels of multiple antibodies Better accuracy and precision Full automation ensures excellent assay performance - Minimizes errors associated with specimen and reagent handling Heterogeneous assay format with magnetic beads - Limits interferences and reduces non-specific binding to improve specificity Excellent reproducibility with total precision at < 10% CV for all analytes Quality assurance in every test Internal quality beads ensure optimal system performance and result integrity - Serum Verification Bead (SVB) confirms the presence of serum/plasma - Internal Standard Bead (ISB) standardizes detector performance - IgA Verification Bead (AVB) flags samples with IgA deficiency Consolidate Testing Platforms and Reagent Kits Traditional Celiac serology testing requires multiple platforms such as a microplate system for anti-ttg and anti-dgp as well as a nephelometer for total IgA levels. Sample aliquoting, batching and coordination between multiple instruments slows reporting of results. The BioPlex 2200 System offers streamlined results reporting. Minimize sample aliquoting optimizing lean workflow Report out negative results faster for improved client satisfaction Streamline reagent kit storage and purchasing activities for improved laboratory efficiency ttg IgA Kit ttg IgG Kit + Total IgA Kit Celiac IgA Kit ttg IgA DGP IgA IgA Verification DGP IgA Kit DGP IgG Kit Celiac IgG Kit ttg IgG DGP IgG Microplate System Nephelometer BioPlex 2200 System The BioPlex 2200 System simplifies your Celiac testing

Excellent Clinical and The BioPlex 2200 Celiac IgA and IgG kits show high clinical sensitivity and specificity using clinically diagnosed, biopsy positive samples. Clinical performance of the BioPlex 2200 Celiac IgA and IgG kits was evaluated in samples from patients previously diagnosed with Celiac Disease (N=157) including 133 adults, 24 pediatric patients, and samples from patients with other autoimmune, infectious and gastrointestinal disease (N=163). The BioPlex 2200 System provides accurate results for Celiac biomarkers High specificity ensures excellent agreement with biopsy results BioPlex 2200 Celiac IgA Kit Clinical and (N=320) BioPlex 2200 Celiac IgA Retrospective Samples Anti-tTG IgA Anti-DGP IgA Celiac Non-Celiac 148 9 136 21 94.3% 98.8% 2 160 5 158 86.6% 96.9% BioPlex 2200 Celiac IgG Kit Clinical and (N=320) BioPlex 2200 Celiac IgG Retrospective Samples Anti-tTG IgG Anti-DGP IgG Celiac Non-Celiac 70 87 133 24 44.6% 95.7% 7 155 5 158 84.7% 96.9%

bioplex 2200 SYSTEM BioPlex 2200 Celiac IgA and IgG Kits The BioPlex 2200 Celiac IgA and IgG kits consolidate four traditional single-analyte tests into two disease state panels for lean laboratory workflow. The Calibrator and Control sets offer ease-of-use and cost savings with 60 day open vial stability and 30 day calibration curve stability. Celiac IgA and IgG Reagent Packs Each reagent pack contains all the necessary reagents (sample diluent, beads and conjugate) to process 100 samples and up to 2 results per sample. Celiac IgA and IgG Calibrator Sets Calibrators are ready-to-use. A 4PL curve fit, using nine calibrators (5 vials for anti-ttg and 5 vials for anti-dpg), is used to calculate semi-quantitative results. Celiac IgA and IgG Control Sets Quality Controls are ready-touse. Each bi-level set includes a negative control as well as a positive control for anti-ttg and anti-dgp. Ordering Information 665-2350 BioPlex 2200 Celiac IgA Reagent Kit...1 pack 663-2300 BioPlex 2200 Celiac IgA Calibrator Set... 1 set 663-2330 BioPlex 2200 Celiac IgA Control Set... 1 set 665-2250 BioPlex 2200 Celiac IgG Reagent Kit...1 pack 663-2200 BioPlex 2200 Celiac IgG Calibrator Set... 1 set 663-2230 BioPlex 2200 Celiac IgG Control Set... 1 set For further information, please contact the Bio-Rad office nearest you or visit our website at www.bio-rad.com/diagnostics Clinical Diagnostics Group Website www.bio-rad.com/diagnostics Australia 61-2-9914-2800 Austria 43-1-877-8901 Belgium 32-9-385-5511 Brazil +55 (31)3689-6600 Canada 1-514-334-4372 China 86-21-61698500 Czech Republic 420-241-430-532 Denmark +45-4452-1000 Finland 358-9-804-22-00 France 33-1-47-95-60-00 Germany +49 (0)89-318-840 Greece 30-210-7774396 Hong Kong 852-2789-3300 Hungary +36-1-459-6100 India 1800-180-1224 Israel 972-3-9636050 Italy +39-02-216091 Japan 81-3-6361-7070 Korea 82-2-3473-4460 Mexico +52 (55)5488-7670 The Netherlands +31-318-540666 New Zealand 64-9-415-2280 Norway +47-23-38-41-30 Poland 48-22-3319999 Portugal 351-21-472-7700 Russia 7-495-721-14-04 Singapore 65-6415-3170 South Africa 27-11-442-85-08 Spain 34-91-590-5200 Sweden 46-8-555-127-00 Switzerland +41 (0)26-674-55-05/06 Taiwan 886-2-2578-7189 Thailand 662-651-8311 United Kingdom +44 (0)20-8328-2000 2013 Bio-Rad Laboratories, Inc. Printed in USA DG13-0190 T-242INTL Rev. 07/2013 Printed on recycled paper with soy-based inks